Effect of Femoral Region Ice Bag Application on Patients' Clinical Outcomes Post-Percutaneous Coronary Intervention
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMansoura University
About this trial
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, necessitating advancements in diagnostic techniques (Parulkar et al., 2025). According to the British Heart Foundation, over 250 million individuals worldwide are living with CAD, making it the most commonly diagnosed heart condition globally. In 2021, CAD was responsible for approximately 9 million deaths, accounting for about one in every seven deaths globally
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
1. Patients with active infections 2. Patient with double femoral sheath region. 3. Patients with bleeding scar tissue from burns, wounds or hematoma in the femoral artery area before sheath removal.
Trial design
Design model
Parallel
Treatments tested in this trial
Ice Bag Application
Other interventioncold therapy, consisting of an ice bag maintained at a temperature of 0-4°C, applied to the femoral region for 20 minutes with 10-minute intervals during the first two hours following PCI
Treatment groups
60 Participants
are divided into 2 treatment groupsGroup A: Ice Bag Application (IBA) GroupOther 1 intervention
Group B: • Routine Care GroupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Pain Level
Assessed using a standardized pain scale
Time frame
3 monthsSecondary outcomes
1
Hematoma Formation
Presence and size of hematoma at the puncture site, measured in centimeters using hematoma scale
Time frame
3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: